The Threat of Impending Pandemics: A Proactive ApproachReview Published on 2023-03-272023-06-10 Journal: Cureus [Category] Fulltext, 원숭이두창, [키워드] Influenza MERS pandemic preparedness SARS zoonosis. [DOI] 10.7759/cureus.36723 PMC 바로가기 [Article Type] Review
Bats-associated beta-coronavirus detection and characterization: First report from PakistanArticle Published on 2023-03-012023-07-11 Journal: Infection, genetics and evolution : journal of mol [Category] COVID19(2023년), [키워드] Bats-borne viruses Coronaviruses MERS molecular detection zoonotic diseases. [DOI] 10.1016/j.meegid.2022.105399 PMC 바로가기
Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domainSARS-CoV-2 S2 도메인에 대한 항체의 결합 및 중화 능력Article Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibodies antibody B.1.1.7 B.1.351 B.1.617.2 B.1.621 binding binding activity carried conserved convalescent patient coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 determined by domain ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated Evidence Immune escape immune protection mAb mAbs MERS MERS-CoV Middle East Middle East respiratory syndrome Middle East respiratory syndrome Coronavirus molecular monoclonal antibodies monoclonal antibody N Terminal N terminal domain NAbs Neutralization assay neutralization assay. Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody NTD P.1 Protein pseudo-virus RBD Receptor binding domain reported Research respiratory Result S protein S proteins S2 protein S2 subunit SARS-CoV SARS-CoV-2 SARS-CoV-2 RBD SARS-CoV-2 S SARS-CoV-2 S2 SARS-CoV-2 WT Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus significantly specific antibodies subunit target targets terminal Vaccine design variant variants wild-type [DOI] 10.1080/21645515.2022.2055373 PMC 바로가기 [Article Type] Article
Antiviral Potential of Plants against COVID-19 during Outbreaks-An UpdateReview Published on 2022-11-052023-08-30 Journal: International Journal of Molecular Sciences [Category] E형 간염, [키워드] Antiviral COVID-19 medicinal plants. MERS SARS [DOI] 10.3390/ijms232113564 PMC 바로가기 [Article Type] Review
Potential intestinal infection and faecal-oral transmission of human coronavirusesArticle Published on 2022-11-012022-11-15 Journal: Reviews in Medical Virology [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome circulating close contact common cold coronavirus coronavirus disease COVID-19 described detectable develop Evidence faecal-oral transmission highlight Human human coronavirus human coronaviruses in vitro in vivo Infection intestinal intestinal infection. manifestation MERS MERS-CoV Middle East occur Occurrence Patient Potential proportion provided Respiratory disease respiratory droplet SARS-CoV SARS-CoV-2 shown Spread Symptoms syndrome Transmission Viral RNA [DOI] 10.1002/rmv.2363 PMC 바로가기
Large-Scale Functionalized Metasurface-Based SARS-CoV-2 Detection and QuantificationArticle Published on 2022-10-252022-11-15 Journal: ACS Nano [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] antibodies asymmetric binding can be used costly demonstrated detection electron Fano resonance Influenza large-scale metasurface MERS Microfluidics molecular offer optical pathogen platform point-of-care Point-of-care detection presenting Proteins Quantitative RNA virus SARS-CoV-2 Sensitivity and specificity Surface plasmon resonance. viral particle [DOI] 10.1021/acsnano.2c02500 PMC 바로가기
Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boostingArticle Published on 2022-10-242022-11-15 Journal: Virology Journal [Category] 치료제, [키워드] Analysis analyzed Antiviral Bioavailability clinical manifestations Corona COVID-19 COVID-19 diagnosis Cytokines determinant drugs facemasks Factor Host hygiene immune immune system immunopathology IMPROVE include Intervention investigated medical intervention MERS morbidity and mortality Nanotechnology narrative pandemic Pandemics pathogenicity Pregnancy quarantine reservoirs respiratory Respiratory pandemics respiratory viral diseases response SARS-CoV-2 Spanish flu Spanish flu. Symptom therapy Toxicity Transmission treat Vaccines virus viruses [DOI] 10.1186/s12985-022-01902-2 PMC 바로가기
Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 diseaseReview Published on 2022-10-192023-07-01 Journal: Medical gas research [Category] COVID19(2023년), SARS, [키워드] coronavirus COVID-19 Immunity MERS Ozone SARS SARS-CoV-2 [DOI] 10.4103/2045-9912.325989 PMC 바로가기 [Article Type] Review
A fast, ultrasensitive SERS immunoassay to detect SARS-CoV-2 in salivaArticle Published on 2022-10-092022-11-15 Journal: Analytica chimica acta [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] Alpha antibody Antigen Concentration COVID-19 COVID-19 pandemic detect Diagnosis diagnostics disease transmission E. coli expressed Genome immunoassay inactivated less MERS Omicron variants point-of-care qRT-PCR Raman spectroscopy recombinant Saliva SARS-CoV-2 SARS-CoV-2 spike proteins SARS-CoV-2 virus scattering scFv Single chain variable fragment (scFv) Spike protein Spike proteins Surface-enhanced Raman scattering (SERS). tested the SARS-CoV-2 the SARS-CoV-2 virus [DOI] 10.1016/j.aca.2022.340290 PMC 바로가기
Current clinical status of new COVID-19 vaccines and immunotherapyArticle Published on 2022-10-012022-11-16 Journal: Environmental science and pollution research inter [Category] COVID19(2023년), SARS, 변종, [키워드] affected antiviral drugs approval caused Children vaccine clinical clinical outcomes clinical status clinical study clinical trial Coronaviridae family COVID-19 covid-19 therapies COVID-19 vaccine current death develop Efficacy expected healthcare worker help human clinical trial Immunotherapy Impact Initially management MERS Nano vaccine pandemic RNA SARS-CoV-2 the WHO therapy treatment approach US-FDA vaccination Vaccine vaccine candidate Vaccine development vaccine. variant Wuhan, China [DOI] 10.1007/s11356-022-22661-1 PMC 바로가기